James Hambro & Partners
- SEC CIK
- 0001731152
- Latest filing
- Jul 23, 2026
NVO holding history
Novo Nordisk A S in every 13F filed by James Hambro & Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVO overviewAll 13F holders of NVOFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −16,090−100.0% | Sold out | Holders |
| Q1 2025 | 16,090 | $1.12M | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 16,090 | $1.38M | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 16,090 | $1.92M | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 16,090 | $2.30M | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 16,090 | $2.07M | 0.1% | +1,000+6.6% | Added | Holders |
| Q4 2023 | 15,090 | $1.56M | 0.1% | +15,090 | New | Holders |